die(' Site is under construction

Dear site users

Site is under construction.

The site will be ready in less than 24 hours.

We are sorry for the inconvenience.

www.yektaweb.com

'); Reports of Biochemistry and Molecular Biology rbmb.net Basic Sciences http://rbmb.net 1 admin 2322-3480 2322-3480 10.61882/rbmb en jalali 1402 5 1 gregorian 2023 8 1 12 2 online 1 fulltext
en Vitamin D and miRNA-155 in Behçet’s Disease: Possible Association with the Disease and Disease Activity ایمنی شناسی Immunology مقالات اصلی Original Article <div style="text-align: justify;"><span style="font-size:10pt"><span style="text-justify:kashida"><span style="text-kashida:0%"><span style="line-height:normal"><span style="tab-stops:396.55pt"><span style="font-family:Calibri,sans-serif"><b><i><span lang="EN-GB" style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="color:black"><span style="letter-spacing:-.3pt">Background:</span></span></span></span></i></b><span lang="EN-GB" style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="color:black"><span style="letter-spacing:-.3pt"> Vitamin D (vit D) controls inflammation and immunity. In Beh&ccedil;et&rsquo;s disease (BD), microRNA-155 is recognized as a significant immune response regulator. We aimed to investigate the role of vit D on immunomodulation and downregulation of inflammatory pathways associated with BD and detect the role of miRNA-155 in BD.</span></span></span></span></span></span></span></span></span></span><br> <br> <span style="font-size:10pt"><span style="text-justify:kashida"><span style="text-kashida:0%"><span style="line-height:normal"><span style="tab-stops:396.55pt"><span style="font-family:Calibri,sans-serif"><b><i><span lang="EN-GB" style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="color:black"><span style="letter-spacing:-.3pt">Methods:</span></span></span></span></i></b> <span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="color:black"><span style="letter-spacing:-.3pt">miRNA-155 expression by Real Time -Polymerase Chain Reaction (RT-PCR), and vit D, nuclear factor Kappa-light-chain-enhancer of activated B cells (NF-&kappa;B), and Tumor necrosis fact of TNF-&alpha;) expression by Enzyme Linked Immunosorbent Assay (ELISA) were assessed.</span></span></span></span></span></span></span></span></span></span><br> <br> <span style="font-size:10pt"><span style="text-justify:kashida"><span style="text-kashida:0%"><span style="line-height:normal"><span style="tab-stops:396.55pt"><span style="font-family:Calibri,sans-serif"><b><i><span lang="EN-GB" style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="color:black"><span style="letter-spacing:-.3pt">Results:</span></span></span></span></i></b><span lang="EN-GB" style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="color:black"><span style="letter-spacing:-.3pt"> BD patients had a significantly higher relative expression of microRNA-155 (P< 0.001), it was significantly related to vascular manifestations (P< 0.001). Vit D relative expression was significantly low in BD (P< 0.001). There was a significant rise in miRNA-155 in the active group compared to the inactive group (P< 0.001). A significant decrease in vit D levels (IU) was found in inactive and active individuals suffering from BD when compared to controls (P< 0.001). A significant rise was found in vit D levels in inactive BD cases (P< 0.001). A significant positive correlations were found between miRNA-155, NF-&kappa;B, TNF-&alpha;, and negative correlations with vit D relative expression in BD patients.</span></span></span></span></span></span></span></span></span></span><br> <br> <span style="font-size:10pt"><span style="text-justify:kashida"><span style="text-kashida:0%"><span style="line-height:normal"><span style="tab-stops:396.55pt"><span style="font-family:Calibri,sans-serif"><b><i><span lang="EN-GB" style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="color:black"><span style="letter-spacing:-.3pt">Conclusions:</span></span></span></span></i></b> <span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="color:black"><span style="letter-spacing:-.3pt">miRNA-155 relative expression is higher in BD is significantly related to vascular manifestations. It may have a relationship to disease activity. Vitamin D relative expression is significantly low in BD patients, which can significantly influence immunomodulatory BD therapy. Vitamin D deficiency linked to active BD.</span></span></span></span></span></span></span></span></span></span></div> miRNA-155, Reverse Transcriptase Polymerase Chain Reaction Behçet’s disease, Vitamin D. 251 258 http://rbmb.net/browse.php?a_code=A-10-1284-1&slc_lang=en&sid=1 Dina Mohamed Mekawy 100319475328460017930 100319475328460017930 No Medical Biochemistry & Molecular Biology, Faculty of Medicine, Cairo University, Egypt & Medical Biochemistry and Molecular Biology, Faculty of Medicine, Badr University, Egypt. Mervat Eissa mervateissa@kasralainy.edu.eg 100319475328460017931 100319475328460017931 Yes Rheumatology Department, Faculty of Medicine, Cairo University, Egypt. Noha Adly Sadik 100319475328460017932 100319475328460017932 No Internal medicine Faculty of Medicine, Cairo University, Egypt. Rana Mohamed Abd-Elrahman 100319475328460017933 100319475328460017933 No Medical Biochemistry & Molecular Biology, Faculty of Medicine, Cairo University, Egypt. Ahmed Fawzy 100319475328460017934 100319475328460017934 No Medical Physiology, Faculty of Medicine, Cairo University, Egypt. Marwa Fathy Amer 100319475328460017935 100319475328460017935 No Medical Biochemistry & Molecular Biology, Faculty of Medicine, Cairo University, Egypt.